Contact

Representative before the EPO

Company dna kernebeck patentanwalts gmbh
no operation time available
1 office
active in Legal Services

We have observed 15 EP applications Thomas Kernebeck has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11738393

MELTING TABLET COMPRISING A TRIPTANE OR ATYPICAL NEUROLEPTIC

IPC classification:
A61K 9/00, A61K 31/404, A61K 31/422, A61K 31/497
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12737470

POWDERY MIXTURE FOR PRODUCING TABLETS CONTAINING LEVETIRACETAM

IPC classification:
A61K 9/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12735463

A NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/10, A61K 9/107, A61K 31/473, A61P 25/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12769586

COMPRESSED SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS PARTICULATE VALSARTAN AS THE ACTIVE INGREDIENT

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/41, A61K 31/549
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14001695

High dose imatinib tablets

IPC classification:
A61K 9/20, A61K 9/28, A61K 31/506
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13004915

Compositions of Imatinib

IPC classification:
A61K 9/28, A61K 31/506
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13702727

PROCESS FOR PRODUCING A SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE ACTIVE INGREDIENT RASAGILINE

IPC classification:
A61K 9/20, A61K 31/135, A61P 25/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13755280

RITONAVIR COMPOSITIONS

IPC classification:
A61K 31/426
Applicant:
Hetero Research Foundation
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13737527

PHARMACEUTICAL PEMETREXED SOLUTION

IPC classification:
A61K 9/00, A61K 31/519, A61K 47/18, A61K 47/20
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14002689

Composition containing Apomorphine and a Divalent Metal Cation

IPC classification:
A61K 9/08, A61K 31/473, A61K 47/02, A61P 25/16
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14724300

DRUG ADMINISTERING DEVICE AND ASSEMBLY METHOD THEREFORE

IPC classification:
A61M 5/24
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP12190933

Solubilized Ibuprofen

IPC classification:
A61K 9/16
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11728584

APPARATUS AND CASE FOR INFUSION EQUIPMENT

IPC classification:
A61M 5/00, A61M 5/14, A61M 5/142, A61M 5/145
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15002887

ORAL FEBUXOSTAT TABLET

IPC classification:
A61K 9/20, A61K 31/426
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
APPLICATION PUBLISHED
EP16000150

METHOD FOR PRODUCING AN APIXABAN GRANULATE

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/4545
Agent:
Thomas Kernebeck, Kernebeck Patentanwalts GmbH
Status:
The application has been published

Please Sign in to use this feature